The mean percentage of iCCA IHC contingent was 90% (range 79-99) in iCCA cases (n = 7), 2% (0-3) in HCC cases (n = 5), and 64% (1-100) in cHCC-CCA cases (n = 8). Here, PRRT2 is linked to hepatocellular carcinoma.